Oseltamivir Prophylactic Regimens Prevent H5N1 Influenza Morbidity and Mortality in a Ferret Model
Open Access
- 1 May 2008
- journal article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 197 (9) , 1315-1323
- https://doi.org/10.1086/586711
Abstract
BackgroundCurrent oseltamivir prophylactic regimens may not be as effective against highly pathogenic H5N1 influenza viruses as they are against lessKeywords
This publication has 29 references indexed in Scilit:
- Oseltamivir Resistance during Treatment of Influenza A (H5N1) InfectionNew England Journal of Medicine, 2005
- Fatal Avian Influenza A (H5N1) in a Child Presenting with Diarrhea Followed by ComaNew England Journal of Medicine, 2005
- Probable Person-to-Person Transmission of Avian Influenza A (H5N1)New England Journal of Medicine, 2005
- Avian Influenza A (H5N1) in 10 Patients in VietnamNew England Journal of Medicine, 2004
- Re-emergence of fatal human influenza A subtype H5N1 diseaseThe Lancet, 2004
- Outbreak of Avian Influenza A(H5N1) Virus Infection in Hong Kong in 1997Clinical Infectious Diseases, 2002
- Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trialThe Lancet, 2000
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virusThe Lancet, 1998
- A pandemic warning?Nature, 1997